Jeffrey M. Dayno Salary and Compensation - Harmony Biosciences Holdings, Inc. CEO Salary 2025

In fiscal year 2025, Jeffrey M. Dayno, M.D. of Harmony Biosciences Holdings, Inc. (HRMY), received total compensation of $7.9 million.

Jeffrey M. Dayno's compensation breakdown includes: base salary of $744K, stock awards valued at $2.0 million, option awards of $4.6 million, non-equity incentive compensation of $558K, and other compensation of $22K.

Compared to fiscal year 2024, Jeffrey M. Dayno's total compensation increased 11% from $7.1 million to $7.9 million.

Harmony Biosciences Holdings, Inc. (HRMY) Executive Pay 2025

Harmony Biosciences Holdings, Inc.'s top 6 named executive officers received combined total compensation of $21.4 million in fiscal year 2025.

The named executive officers disclosed in Harmony Biosciences Holdings, Inc.'s 2025 proxy statement are:Jeffrey M. Dayno (M.D.) with total compensation of $7.9 million, Adam Zaeske with total compensation of $3.7 million, Sandip Kapadia (EVP and Chief Financial Officer and) with total compensation of $3.2 million, Jeffrey Dierks (Former EVP and Chief Commercial) with total compensation of $2.3 million, Kumar Budur (EVP and Chief Medical & Scientific) with total compensation of $2.3 million, and Andrew Serafin (EVP Chief Strategy Officer) with total compensation of $2.0 million.